Susquehanna initiates coverage on Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) with a Positive. Price target $3.

Susquehanna analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE